Search Results 121-130 of 20559 for Ulcerative+colitis

1. Mirikizumab-mrkz (intravenous route, subcutaneous route) - Side effects & dosage - Mayo Clinic

   Mirikizumab-mrkz injection is used to treat moderate to severe active Crohn's disease and ulcerative colitis. This medicine is available only with your ...

2. Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

   Clinical Trials · Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis · More about research ...

3. Publications - Talha A. Malik, M.D. - Mayo Clinic

   Acute Severe Ulcerative Colitis (ASUC): Clinical Features, Initial Management, and the Role of Advanced Therapies. Biomedicines. 2025 Oct 18; 13(10). View ...

4. Ileoanal anastomosis (J-pouch) surgery - Mayo Clinic

   This surgery removes the large intestine. It's often done to treat ulcerative colitis and other bowel conditions.

5. AMG 181 Phase 2 Study in Subjects with Moderate to Severe Ulcerative Colitis - Mayo Clinic

   AMG 181 Phase 2 Study in Subjects with Moderate to Severe Ulcerative Colitis · More about research at Mayo Clinic · Mayo Clinic Footer.

6. A Study of the Effectiveness and Safety of Vedolizumab Compared to Adalimumab for Participants with Ulcerative Colitis - Mayo Clinic

   Clinical Trials · A Study of the Effectiveness and Safety of Vedolizumab Compared to Adalimumab for Participants with Ulcerative Colitis · More about research at ...

7. A Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA) - Mayo Clinic

   A Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA) ... Ulcerative Colitis (UC) or Crohn's disease ...

8. Study of the Effect of SHP647 as Maintenance Treatment in Participants with Moderate to Severe Ulcerative Colitis who Achieved Clinical Response in Induction Studies - Mayo Clinic

   The purpose of this study is to evaluate the efficacy of SHP647 as maintenance therapy in participants with moderate to severe ulcerative colitis (UC) who ...

9. A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vixarelimab in Participants With Moderate to Severe Ulcerative Colitis (UC) - Mayo Clinic

   A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vixarelimab in Participants With Moderate to Severe Ulcerative Colitis (UC). Print details.

10. A Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects with Ulcerative Colitis - Mayo Clinic

    The purpose of this study is to evaluate the safety, tolerability and microbiome dynamics of SER-287 in subjects with mild-to-moderate ulcerative colitis.